Cooler News: Managing the Supply Chain During the Pandemic

 

Even in the earliest days of the pandemic, the spotlight was on national and global supply chains. How would they hold up if the worst came to pass? Now several months into that world-wide crisis, Jeff Monroe, Director of Supply Chain at KPS Global, spoke about the challenges of supply chain management during the time of COVID-19 and how KPS found ways to overcome those obstacles and maintain integrity of the supply chain for its customer base

“Like many organizations, KPS has a global supply chain,” Monroe said. “We had to think quickly and make changes along the way. We did a good job of staying ahead of COVID.”

But Monroe noted, “We buy a fair amount of completed items from suppliers also impacted by the pandemic. First, the impact was on their ability to get parts, and now it’s their workforce. I’d say every part of our supply chain felt the impact and is still feeling it today.”

While Monroe said KPS’s supply chain didn’t feel an immediate impact from the pandemic, “the most pressing issue from the beginning was buyouts (those complete product purchases from suppliers.)

“The challenge we faced was a dwindling supplier stock at the reorder point. We kept regular communication with our suppliers to know what was going on and find alternate options if product wasn’t available.”

A side effect of the tariffs KPS experienced in 2019 were some unexpected benefits in dealing with the pandemic. Monroe and his team were already engaged in finding sourcing solutions to mitigate the impact tariffs had on their supply chain.

“Because of the tariffs situation, we started to dive into our supply chain a little bit deeper and understand our costs,” Monroe said. “We found some of our local suppliers could also get us many of the parts and products, or suitable alternatives, we needed.”

These additional sources helped reduce tariffs for KPS and proved beneficial in navigating the pandemic.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More